Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007. (Q37321101)

19 August 2017

Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007. (English)

1 reference

Vaccine Adverse Event Reporting System

19 August 2017

1 reference

based on heuristic

inferred from title

vaccine adverse event

1 reference

Manette T Niu

1

1 reference

19 August 2017

Robert Ball

2

1 reference

19 August 2017

Emily Jane Woo

3

1 reference

19 August 2017

Dale R Burwen

4

1 reference

19 August 2017

Maureen Knippen

5

1 reference

19 August 2017

M Miles Braun

6

1 reference

19 August 2017

VAERS Working Group

7

1 reference

19 August 2017

language of work or name

English

0 references

publication date

6 November 2008

1 reference

19 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

19 August 2017

27

1 reference

19 August 2017

2

1 reference

19 August 2017

290-297

1 reference

Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

In their own words: lessons learned from those exposed to anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

UK armed forces responses to an informed consent policy for anthrax vaccination: A paradoxical effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Media coverage of anthrax vaccination refusal by Australian Defence Force personnel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Field Evaluation of a Human Anthrax Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Anthrax vaccine: short-term safety experience in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Comparing data mining methods on the VAERS database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System (VAERS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Adverse events after hepatitis A B combination vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Chronic multisymptom illness affecting Air Force veterans of the Gulf War.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Oral pemphigus vulgaris after anthrax vaccine administration: association or coincidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

New-onset rheumatoid arthritis after anthrax vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Lymphocytic vasculitis associated with the anthrax vaccine: case report and review of anthrax vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Optic neuritis after anthrax vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Aluminum-containing vaccine associated adverse events: role of route of administration and gender

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

ALS in Rochester, Minnesota, 1925-1977.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Occurrence of amyotrophic lateral sclerosis among Gulf War veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Excess incidence of ALS in young Gulf War veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Prospective study of military service and mortality from ALS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

7 January 2021

ALS and military service

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Vaccination and autoimmune disease: what is the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Vaccination associated thrombocytopenic purpura in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

MMR vaccine and idiopathic thrombocytopaenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Epidemiology of autoimmune diseases in Denmark

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Epidemiology of rheumatoid arthritis: update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

The current neurologic burden of illness and injury in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Acute transverse myelitis: incidence and etiologic considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Proposed diagnostic criteria and nosology of acute transverse myelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Intussusception among infants given an oral rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

Strengthening the validity of population-based suicide rate comparisons: an illustration using U.S. military and civilian data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.044

10.1016/J.VACCINE.2008.10.044

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference